OTCMKTS:KMLXF Respiri (KMLXF) Stock Price, News & Analysis $0.0006 0.00 (0.00%) As of 05/29/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Respiri Stock (OTCMKTS:KMLXF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Respiri alerts:Sign Up Key Stats Today's Range$0.0006▼$0.000650-Day Range N/A52-Week Range$0.04▼$0.05VolumeN/AAverage Volume6,100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Respiri (OTCMKTS:KMLXF) is a digital health company focused on empowering patients with respiratory conditions through connected monitoring solutions. The company’s flagship offering, wheezo®, is a compact sensor that attaches directly to a patient’s inhaler, capturing airflow data and wheezing patterns during use. This device syncs with a companion smartphone application, enabling users and healthcare providers to track treatment adherence, symptom trends and early signs of exacerbation in real time. In addition to its inhaler‐based sensor, Respiri operates a cloud‐hosted analytics platform that aggregates patient data for remote monitoring and telehealth integration. The platform generates reports and alerts that clinicians can use to adjust treatment plans, enhance preventive care and reduce the risk of hospital visits. Designed for patients with asthma, chronic obstructive pulmonary disease (COPD) and other respiratory conditions, Respiri’s solution aims to bridge gaps in disease management by offering objective, continuous measurements outside the clinic. Founded in Australia and headquartered in Melbourne, Respiri has secured CE marking for wheezo® and launched commercial operations across Australia, New Zealand and selected European markets. The company continues to pursue regulatory clearances and strategic partnerships to expand its geographic footprint, with a focus on strengthening ties with healthcare providers, pharmacies and research institutions. Through ongoing product development and clinical collaborations, Respiri seeks to establish itself as a leader in home‐based respiratory monitoring and digital therapeutics.AI Generated. May Contain Errors. Read More Receive KMLXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Respiri and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KMLXF Stock News HeadlinesVitasora Health Rebrands and Updates ASX TickerApril 22, 2025 | tipranks.comRespiri Limited Announces Successful Resolutions at General MeetingApril 15, 2025 | tipranks.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.May 30 at 1:00 AM | InvestorPlace (Ad)Respiri Limited Strengthens U.S. Market Position Amid Policy and Trade DevelopmentsApril 8, 2025 | tipranks.comRespiri Limited Proposes Name Change to Vitasora Health LimitedMarch 16, 2025 | tipranks.comRespiri Limited to Hold Virtual General Meeting in April 2025March 16, 2025 | tipranks.comRespiri Limited Announces USA Growth Plans and Major DealsMarch 16, 2025 | tipranks.comRespiri Limited to Unveil U.S. Growth Plans in Upcoming WebinarMarch 13, 2025 | tipranks.comSee More Headlines KMLXF Stock Analysis - Frequently Asked Questions How have KMLXF shares performed this year? Respiri's stock was trading at $0.0581 at the beginning of 2026. Since then, KMLXF stock has decreased by 99.0% and is now trading at $0.0006. How do I buy shares of Respiri? Shares of KMLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/30/2026Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private Households Sub-IndustryPersonal Services Current SymbolOTCMKTS:KMLXF CIKN/A Webwww.respiri.co Phone61 3 9653 9160Fax61 -0-3 9602 3606EmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.07 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta0.07 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:KMLXF) was last updated on 5/30/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredPresident Trump just sparked a stock market MELT UPThe real reason Musk, Huang, Cook, and Fink just flew to Beijing Last week, the CEOs of Nvidia, Apple, Spac...Stansberry Research | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredSkip the Line Opportunity: The SpaceX IPOFormer tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...Brownstone Research | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Respiri Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Respiri With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.